| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
The American Dental Company offers member dentists access to sophisticated practice marketing and patient communications products and services with the benefit of group purchase pricing. Mr. Bobrow also serves as Executive Director of Dentists' Climb
paramedics plus is a Tyler, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Dimensions is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
East Texas Council on Alcoholism is a Longview, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.